Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favorable outcome in elderly Asian patients with metastatic renal cell carcinoma treated with everolimus: the Osaka Urologic Oncology Group.
Inamoto T, Azuma H, Nonomura N, Nakatani T, Matsuda T, Nozawa M, Ueda T, Kinoshita H, Nishimura K, Kanayama HO, Miki T, Tomita Y, Yoshioka T, Tsujihata M, Uemura H. Inamoto T, et al. Among authors: yoshioka t. Asian Pac J Cancer Prev. 2014;15(4):1811-5. doi: 10.7314/apjcp.2014.15.4.1811. Asian Pac J Cancer Prev. 2014. PMID: 24641414 Free article.
Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma.
Kawashima A, Tsujimura A, Takayama H, Arai Y, Nin M, Tanigawa G, Yasunaga Y, Mukai M, Uemura M, Nakai Y, Nishimura K, Nonomura N; Osaka Renal Cell Carcinoma Clinical Study Collaboration. Kawashima A, et al. Med Oncol. 2012 Dec;29(5):3298-305. doi: 10.1007/s12032-012-0236-6. Epub 2012 Apr 29. Med Oncol. 2012. PMID: 22544539
Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma.
Kawashima A, Uemura M, Kato T, Ujike T, Nagahara A, Fujita K, Imamura R, Yamanaka Y, Tomiyama E, Tanigawa G, Miyagawa Y, Yoshioka T, Miyake O, Nonomura N. Kawashima A, et al. Among authors: yoshioka t. Int J Clin Oncol. 2019 Jan;24(1):78-86. doi: 10.1007/s10147-018-1332-1. Epub 2018 Aug 9. Int J Clin Oncol. 2019. PMID: 30094693 Free PMC article.
Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer.
Kawashima A, Nakayama M, Kakuta Y, Abe T, Hatano K, Mukai M, Nagahara A, Nakai Y, Oka D, Takayama H, Yoshioka T, Hoshida Y, Itatani H, Nishimura K, Nonomura N. Kawashima A, et al. Among authors: yoshioka t. Clin Cancer Res. 2011 Apr 15;17(8):2561-9. doi: 10.1158/1078-0432.CCR-10-1963. Epub 2010 Dec 21. Clin Cancer Res. 2011. PMID: 21177407
[Clinical study of upper urinary tract carcinoma].
Saito J, Kanemitsu T, Sato M, Mori N, Nakatsuka S, Sekii K, Yoshioka T, Itatani H. Saito J, et al. Among authors: yoshioka t. Nihon Hinyokika Gakkai Zasshi. 2009 Sep;100(6):609-14. doi: 10.5980/jpnjurol.100.609. Nihon Hinyokika Gakkai Zasshi. 2009. PMID: 19827537 Japanese.
2,343 results